Novavax ends sale agreement with Gavi
Novavax Inc. announced that it had sent a written notification to Gavi, the Vaccine Alliance, terminating with immediate effect an agreement for the sale of its COVID-19 vaccine to low- and middle-income nations. The business cited Gavi's failure to acquire the 350 million doses it had